home / stock / gild / gild articles

GILD Articles, Gilead Sciences Inc. - From 11/07/23

Stock Information
Company Name: Gilead Sciences Inc.
Stock Symbol: GILD
Market: NASDAQ
Website: gilead.com
Menu
GILD GILD Quote GILD Short GILD News GILD Articles GILD Message Board
Get GILD Alerts

News, Short Squeeze, Breakout and More Instantly...
Positive News For Gastric Cancers - Gilead/Arcus Biosciences' Combination Cancer Therapy Shows Encouraging Clinical Activity | Benzinga

Gilead Sciences Inc (NASDAQ: GILD) and Arcus Biosciences Inc (NYSE: RCUS) announced that domvanalimab plus zimberelimab and chemothe...
S&P 500, Nasdaq Set To Break 6-Day Rally Today? Traders Await Fed Cues, Analyst Says Seasonal Rally Has Started With Gusto | Benzinga

Sentiment appears to have dipped after a six-session winning streak. Stock futures indicate a modestly lower opening on Tuesday as small and mid-ca...

If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,200 Today | Benzinga

Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years by 5.88% on an annualized basis producing an average annual return...

Leidos Sees Robust Demand In Digital Modernization, Raises Annual Outlook | Benzinga

Leidos Holdings, Inc (NYSE: LDOS) reported third-quarter FY23 revenue growth of 9% year-over-year to $3.92 billion, beating the consensus of $...
Comparative Study: Gilead Sciences And Industry Competitors In Biotechnology Industry | Benzinga

Amidst the fast-paced and highly competitive business environment of today, conducting comprehensive company analysis is essential for investors an...

Pfizer Decides To Raise COVID-19 Treatment Pill Price, Defends Itself Amid Criticism for Cost Increase | Benzinga

Pfizer Inc (NYSE: PFE) is reportedly gearing up to price its Covid-19 drug Paxlovid at $1,390 for a five-day course, more than double what the...

Vertex Pharmaceuticals, Gilead Sciences And 2 Other Stocks Insiders Are Selling | Benzinga

The Nasdaq 100 closed lower by over 200 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell share...
Hepatitis-Focused Assembly Biosciences Stock Trading Over 100% Higher: Here's Why | Benzinga

Gilead Sciences Inc (NASDAQ: GILD) and Assembly Biosciences Inc (NASDAQ: ASMB) have entered into a 12-year partnership. Their goal i...

Here's How Much $100 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today | Benzinga

Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years by 4.82% on an annualized basis producing an average annual return...

Two Trial Halts In A Row - Gilead Sciences Stops Late Stage COVID-19 Study | Benzinga

Gilead Sciences Inc (NASDAQ: GILD) said it has stopped patient enrollment in BIRCH (Study GS-US-611-6273), a Phase 3 study...
Previous 10 Next 10